Despite its proven efficacy, the Cox-Maze III procedure did not gain widespread acceptance for the treatment of lone atrial fibrillation (LAF) because of its complexity and technical difficulty. Surgical ablation for LAF can now be successfully performed utilizing minimally invasive techniques. This article provides an overview of the current state of the art in the surgical treatment of LAF. A brief review of pathophysiology, pharmacological treatment as well as catheter ablation is also provided. The most widely employed minimally invasive approach to LAF has been the video-assisted bilateral mini-thoracotomy or thoracoscopic pulmonary vein island creation and left atrial appendage removal or exclusion, usually with ganglionic plexi evaluation and destruction. Recently, a hybrid approach has been introduced, which combines a mono or bilateral epicardial approach with a percutaneous endocardial ablation in a single-step procedure to limit the shortcomings of both techniques. Suboptimal results of both catheter ablation and surgery suggest that success in the treatment of LAF will probably rely on a close collaboration between the surgeon and the electrophysiologist. Further studies are warranted to determine whether the hybrid approach is effective, especially in patients with long-standing persistent and persistent LAF.
INTRODUCTION
Atrial fibrillation (AF) is the commonest sustained cardiac arrhythmia and is associated with increased morbidity and mortality [1] . It is commonly associated with a number of cardiac and non-cardiac risk factors including ischaemic heart disease, cardiac failure, valvular heart disease, hypertension, diabetes, alcohol abuse, thyroid disorders and pulmonary disease [2] [3] [4] [5] . Nonetheless, in a not negligible percentage of people presenting with AF, there is no identifiable aetiology and this subset of patients is often referred to as 'lone AF' (LAF) [6] .
In this report, we will (i) review clinical results of mini-Maze and minimally invasive surgical ablation of LAF; (ii) provide a brief overview of pathophysiology, pharmacological treatment as well as catheter ablation; (iii) discuss the importance of management of left atrial appendage (LAA); (iv) examine new approaches involving both surgeons and electrophysiologists (EPs); (v) discuss future directions in the treatment of LAF.
A brief history of AF, its incidence and prevalence and its physiopathology are discussed in Supplementary Materials.
DEFINITION OF LONE ATRIAL FIBRILLATION
ACC/AHA/ESC guidelines [7] applied the term LAF to '… individuals younger than 60 years without clinical or echocardiographic evidence of cardiopulmonary disease, including hypertension'. A recent international consensus on nomenclature and classification of AF mentions that only AF in the absence of heart disease is termed 'lone' while in the absence of any disease is termed 'idiopathic' [8] . Indeed, LAF does not necessarily mean 'idiopathic'. In addition, in recent years, an increasing body of evidence has indicated several novel epidemiological and pathophysiological associations of AF. It could therefore be hypothesized that many of the recorded lone or idiopathic AF cases are linked to other not well-known factors. However, the diagnosis of LAF is essentially a diagnosis of exclusion, and should be preceded by careful evaluation, including a thorough collection of the patient's medical history, physical examination, blood pressure measurement, laboratory tests, ECG, echocardiography and, according to some experts, chest X-ray and exercise testing [7] .
(iii) Persistent AF is present when an AF episode either lasts >7 days or requires termination by cardioversion, either with drugs or by direct current cardioversion. (iv) Long-standing persistent AF has lasted for ≥1 year when it is decided to adopt a rhythm control strategy. (v) Permanent AF is said to exist when the presence of the arrhythmia is accepted by the patient (and physician).
MEDICAL TREATMENT: AN OVERVIEW AND THE LATEST UPDATES
According to the current guidelines amiodarone, dronedarone, flecainide, propafenone and I-sotalol are recommended for rhythm control [9] . In selected highly symptomatic patients with occasional recurrences of AF (i.e. between once per month and once per year), the 'pill-in-the-pocket' approach consisting in oral propafenone (450-600 mg) or flecainide (200-300 mg) may be used [10] . Drugs commonly used for rate control are β-blockers, non-dihydropyridine calcium channel antagonists and digitalis. Amiodarone may be suitable for some patients with otherwise refractory rate control [9] . Recommendations for antithrombotic therapy should be based on the presence (or absence) of risk factors for stroke and thrombo-embolism. Unless contraindicated, chronic oral anticoagulation (OAC) therapy is recommended in patients with a CHADS2 [cardiac failure, hypertension, age, diabetes, stroke (doubled)] score ≥2 to achieve an international normalized ratio (INR) value of 2.0-3.0. In patients with CHADS 2 0-1 the CHA 2 DS 2 -VAS c [congestive heart failure, hypertension, age ≥75 (doubled), diabetes, stroke (doubled), vascular disease, age 65-74 and sex category (female)] score is recommended and OAC therapy is suggested if the CHA2DS2-VASc score >2 [9] . (More information can be found in Supplementary Materials).
CATHETER ABLATION: PRESENT AND FUTURE: READY FOR FIRST-LINE THERAPY?
Different approaches proposed for catheter ablation include: (a) segmental/ostial pulmonary vein (PV) isolation; (b) circumferential PV ablation; (c) circumferential/antral PV isolation; (d) electrogram-based ablation or complex fractionated atrial electrograms (CFAEs) ablation; (e) linear lesions; (f ) autonomic ganglionated plexi ablation; (g) ablation of AF Nest; (h) sequential ablation strategy. Details are discussed in Supplementary Materials. The absence of new antiarrhythmics with an improved benefit/risk profile as well as the results of several recently published clinical trials demonstrating superior outcomes with catheter ablation for AF relative to antiarrhythmic drug therapy suggest that AF ablation may warrant consideration as first-line therapy in selected patients [11] .
Nonetheless, complications are not infrequent [12] and there is no full consensus about AF ablation as first-line therapy. Areas of concern are the variable short-term efficacy of catheter ablation, its unknown long-term efficacy, significant procedurerelated complications and the significant variance of success among laboratories using similar techniques of ablation [13] . (More details are given in Supplementary Materials).
SURGICAL TREATMENT

Indications for surgery
Based on the Heart Rhythm Society/ European Heart Rhythm Association/ European Cardiac Arrhythmia Society (HRS/EHRA/ ECA) expert consensus statement on catheter and surgical ablation of AF [7] , 'Stand-alone' AF surgery should be considered for symptomatic AF patients (i) who prefer a surgical approach (ii) who have failed one or more attempts at catheter ablation (iii) who are not candidates for catheter ablation. Surgery ought to be preferred also in the following cases:
(a) Patients who have developed a contraindication to warfarin and who will benefit from the elimination of the LAA at surgery which reduces the incidence of postoperative stroke [14] . (b) Patients with a left atrial thrombus which represents a contraindication to catheter-based ablation (c) large left atria >5 cm (Relative indication).
HOW TO REPORT SURGICAL RESULTS
The Workforce on Evidence Based Surgery of the Society of Thoracic Surgeons (STS) [15] has recently encouraged the adoption of common criteria for reporting clinical results after procedures for AF to facilitate the comparison between experiences of various authors treating different cohorts of AF patients, at different times with different techniques.
Waiting for devices enabling more continuous and accurate monitoring of cardiac rhythm, a compromise approach is to analyse all of the intermittent data available in terms of timerelated prevalence (burden) of AF.
Unfortunately, these criteria have not been adopted worldwide yet. For this reason, we report the success rate as originally published by authors.
SURGICAL PROCEDURES
The Cox-Maze III technique Table 1 summarizes results of 'cut and sew Maze' in published studies reporting a variable percentages of patients with LAF.
The Maze procedure requires cardiopulmonary bypass and cardiac arrest and, also in experienced hands, it requires 45-60 min of cardiopulmonary bypass and cardiac arrest [16] . Thus, even with these modifications, the Maze III remained a complex procedure and this may explain why many surgeons worldwide are reluctant to perform this procedure.
Surgical ablation techniques
On the basis of advances in the understanding of the pathophysiology of AF (Fig. 1) , a variety of new ablation tools have been developed to facilitate surgical ablation of AF. These probes and catheters rely on alternative energy sources to create long, continuous, linear lesions that block conduction. 
Energy sources
The various energy sources differ mainly in the method by which they transfer energy to the tissue and how deeply that energy is conducted into the tissue. Table 2 shows the energy sources available for the clinical use with their advantages and disadvantages.
The Cox-Maze IV technique
In 2002, a new iteration of the Cox-Maze procedure was introduced, termed the Cox-Maze IV procedure, which replaced most of the incisions with linear lines of bipolar radiofrequency ablation [17] . Conflicting results were reported after the CoxMaze IV technique [18, 19] . The Group of Damiano [20] had previously carried out a propensity analysis of matched patients undergoing the Cox-Maze III versus Cox-Maze IV procedures which showed that there was no significant difference between these two procedures in terms of the rates of freedom from AF at 3, 6 and 12 months with the advantage of shortening operative times while maintaining the efficacy of the traditional cut-and-sew Cox-Maze III. Nonetheless, sternotomy and cardiopulmonary bypass are invasive procedures with substantial associated morbidity which most patients are willing to avoid for treatment of AF. Table 1 shows the published study employing the Cox-Maze IV procedure and including patients with LAF.
MINIMALLY INVASIVE SURGERY
Bilateral thoracoscopic approach
The most widely employed minimally invasive approach to LAF has been the video-assisted bilateral mini-thoracotomy or thoracoscopic PV island creation and LAA removal or exclusion, usually with ganglionic plexus evaluation and destruction. Most surgeons prefer this approach to avoid the difficult passage of the ablation device around the PVs (through the transverse and the oblique sinus) when performing a monolateral thoracoscopic approach.
The percentage of success with this technique ranged from 42 to 91% in published papers (excluding case reports) at follow-up ranging from 6 and 40 months (Table 3) .
Right-side thoracoscopic approach
A right-sided port approach with two or three ports has been described by several authors (Table 3) . Initially, microwave (MW) technology was employed followed by laser and unipolar suction-assisted radiofrequency. Unfortunately, significant published assessments are lacking and the only substantial reports available are for MW technology.
This approach is promising, although a limitation potentially includes the inability to remove the LAA. For this reason, Balkhy et al. [21] combined the right thoracoscopic MW ablation with the incorporation of a new device for LAA exclusion (Surg-ASSIST computer-mediated thoracoscopic stapling system [Power Medical Intervention, New Hope, PA, USA]).
More recently, Solinas et al. [22] employed a bipolar irrigated radiofrequency source through a monolateral right thoracotomy for left atrial ablation during minimally invasive mitral surgery. No data exist in the current literature about the feasibility of bipolar RF ablation through a right-side monolateral access in patients with LAF which would combine the benefits for patients of a less-invasive procedure with the advantages of bipolar technology. Dielectric heating created by electromagnetic waves emitted from an antenna (300 MHz-300 GHz).
Produces high-energy optical waves via an optical coupling fibre and radiating fibre tip.
It involves propagation of sound waves from a transducer vibrating at a fixed frequency between 2 and 20 MHz.
Radiofrequency energy uses an alternating current in the range of 100-1000 Hz.
Alternating current is driven between two closely approximated electrodes, which results in a focused ablation. Three phases:
Microwave probes allow for rapid heat penetration. Thermal damage leads to subsequent scar formation.
Tissue is ablated by direct heating and also by mechanical damage for cellular lysis caused by shock waves.
Tissue injury is created through a combination of thermal energy (tissue absorption and acoustic energy) and mechanical energy (oscillation and collapse of gas bubbles or microcavitation.
The energy is dispersed between the electrode tip and a different electrode, usually the grounding pad applied to the patient.
Results in discrete, transmural lesions with no evidence of contraction or scarring.
The laser creates well demarcated and narrow ablation lines because the light beam is collimated and heats the tissue directly without dispersion.
The tissue within 2-3 mm from the probe is heated to 50-60°C with permanent destruction of cell structures and collagen. 
Continued
Right-side thoracotomy approach
A full Maze lesion set using a right thoracotomy and a beating heart on cardiopulmonary bypass has been performed clinically with cryothermia (Table 3 ). More recently, Lee et al. [23] published their results in 22 consecutive LAF patients undergoing RF ablation through a right-side thoracotomy approach. If these results are confirmed, this approach has an important role to play in the treatment of LAF.
Left-side thoracoscopic approach
Grandmougin and Tiffet [24] presented a case of a 68-year old female with permanent LAF who, due to consequences resulting from chemotherapy and OAC, underwent left-side video-assisted thoracoscopic drainage associated with successful epicardial radiofrequency isolation of the PVs (stable SR at 3-month followup). On the basis of this experience, the authors raised the question of whether to perform ablation of both right and left PVs in the same operation rather than delaying an additional ablation of the controlateral side according to rhythmologic results.
Exclusion/excision of the left atrial appendage
Excision or exclusion of the LAA is currently performed during surgical ablation of AF and is recommended in EHRA/HRS guidelines. Recently, there has been great interest in development and assessment of endocardial and epicardial procedures for exclusion of the LAA [25] . Many of these approaches now use a stapler to exclude the appendage or, in some instances, endocardial suture exclusion. Nonetheless, Kanderian et al. [26] , demonstrated, at transoesophageal echocardiography (TEE) that only 55 of 137 (40%) of closures were successful and that an LAA closure occurred more often with excision (73%) than suture exclusion (23%) and stapler exclusion (0%, P > 0.001).
In the literature available, the ligation/exclusion of LAA was performed in 618 (83.6%) patients undergoing minimally invasive surgical ablation for LAF. The occurrence of perioperative cerebrovascular accident was low (0.32%) [27, 28] and comparable with the Cox-Maze procedure (0.5%) [29] . Alike, the occurrence of cerebrovascular accident during the follow-up was low (0.64%) and this figure compares favourably with occurrence rates reported after the Cox-Maze operation [29, 30] . However, notably, the percentage of patients with anticoagulant therapy was much lower in Cox-Maze (16.3%) compared with minimally invasive LAF patients (n = 214, 31.4%).
From our review, the procedure resulted to be safe. Indeed, among LAF patients undergoing minimally invasive surgical ablation and LAA ligation/excision, we found only a case (0.16%) of serious complication related to tearing of the base of the LAA [31] .
However, all these figures were not the result of a meta-analysis of quantitative studies. Furthermore, the small number of patients undergoing minimally invasive surgery without a concomitant LAA procedure does not allow us to draw any conclusion. Finally, it remains still unclear whether it is better to retain LAA which largely contributes to left atrial booster function [32] . It cannot be excluded that crater formation carries a theoretical risk of thromboembolic events. 
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The hybrid approach
The rationale of the so-called 'hybrid' approach is to combine a step-by-step (Fig. 2 ) minimally invasive epicardial technique with a percutaneous endocardial ablation in order to limit the shortcomings of both techniques and, at the same time, to combine their advantages. The concept of 'hybrid' procedure was first published by Pak et al. [33] who combined percutaneous epicardial catheter ablation (PECA) and endocardial ablation in difficult cases of AF. More recently, Krul et al. [34] presented their experience with thoracoscopic PV isolation and ganglionated plexus (GP) ablation guided by peri-procedural electrophysiological testing resulting in a single-procedure success rate of 86%.
Mahapatra et al. [35] have recently published their initial experience with surgical epicardial-catheter and endocardial ablation for persistent and long-standing persistent AF carried out in two sequential steps. After a mean follow-up of 20.7 ± 4.5 months, 86.7% patients were free of any atrial arrhythmia and off of antyarrhythmic drugs (AADs). This figure was 53.3% in patients undergoing catheter-alone procedure (P = 0.04).
Our group had previously published the experience with the hybrid procedure performed in two steps: 17 patients had first endocardial catheter isolation of PVs and due to recurrence of persistent AF were selected for epicardial approach (29% in SR at 25.7 ± 12-month follow-up) whereas 20 patients underwent first epicardial procedure with a subsequent completion of PVs isolation (55% in SR at 33.4 ± 12-month follow-up) [36] . More recently, we have introduced in our practice a sequential 'one-step' approach including an epicardial procedure followed by endocardial catheter radiofrequency. One-year off-AAD success rate free of AF/atrial flutter/atrial tachycardia was 93% for patients with paroxysmal AF and 90% for patients with persistent AF [37] . The hybrid approach presents some potential advantages: (i) there is no risk of tamponade during the trans-septal puncture since the pericardium is open. (ii) The surgeon can protect the phrenic nerves and the oesophagus and the effective surgical ablation reduces the fluoroscopy time. (iii) Since the surgical ablation device is located on the antrum of the left atrium and left as a radiopaque marker, it is almost impossible to create stenosis of the PVs. (iv) Most of the ablation lines are made epicardially, therefore the number of endocardial application ablation lines employed is small with consequent reduction in the occurrence of embolic events which may complicate the endocardial ablation.
Potential disadvantages are: (i) the procedure is time consuming and significantly longer than surgery-alone techniques and (ii) the heparinization of the patient after the septal puncture might cause bleeding of surgically dissected areas.
However, the efficacy of this procedure as well as its potential superiority over catheter ablation or standard surgical technique has to be proven by large comparative studies. Figure 3A -D depicts some endpoints reached at the end of the hybrid procedure.
A GLANCE AT THE FUTURE
The treatment of LAF continues to progress and the future of surgery will focus on two areas: better understanding of the mechanism of LAF and developing techniques that are progressively less invasive.
In understanding the mechanism of AF, more studies are now more focused on the autonomic ganglia that are located around the PVs, so they might be the true triggers and have a major role in the maintenance of AF and it is still disputed whether autonomic ganglia could reconnect or regrow [31] .
Ideally, the mechanism of AF should be defined before planning surgery but, unfortunately, the mapping systems available for non-invasive endocardial mapping have poor resolution and, although electrophysiologists have been able to map highfrequency activation in PVs as well as CFEAs, some patients require more sophisticated waveform. The epicardial activation sequence mapping has been the gold standard for this [38] but, unfortunately it is invasive and time-consuming. For this reason, some groups have developed frequency mapping [39, 40] , which identifies the fastest activating regions during FA. It requires very little subjective analysis and can be done in real time.
Furthermore, in the area of non-invasive method to accurately diagnose AF patients, electrocardiogram imaging is a promising technique [41] . An inverse solution can be calculated by using anatomical information obtained by the computed tomography scan made at the time of the recording. Electrograms can be reconstructed on the atrial epicardial surface. Figure 3 : (A) Conversion of atrial flutter to sinus rhythm: it is a typical counterclockwise flutter during hybrid AF ablation. During endocardial ablation of the posterior isthmus, there is conversion to sinus rhythm. This was also the endpoint of the procedure. (B) Closure of the box lesion: after the isolation of the PVs and making the roof and inferior line there was still a gap were the roofline meets the line around the left PVs. Indeed, the clamp was too short to isolate the left PVs. The figure shows very late pulmonary vein potentials on Lasso 7-8 and 8-9 (410 ms after pacing artefact in the coronary sinus). In the following beat, those signals are disappeared due to a complete isolation of the box and left pulmonary veins. (C) Conversion of atrial tachycardia to sinus rhythm: during hybrid procedure, AF organized to atrial tachycardia. By endocardial ablation at the base of the right atrial appendage, we had conversion to sinus rhythm. This was the endpoint of the procedure. (D) Endocardial exit block from the box: the figure shows pacing and local capture in the box (signals on Lasso 6-7 and 7-8, the Lasso catheter is within the box in this case!) and lack of conduction to the LA during sinus rhythm.
Although no publication has described them yet, other less invasive techniques are under evaluation, such as the subxiphoid approach [42] .
CONCLUSIONS
Results of minimally invasive surgery are controversial with success rates that are highly variable although these results are likely to increase as the procedure progresses. This, along with suboptimal results of catheter ablation, suggests that the success rate in the treatment of LAF will probably rely on a close collaboration between the surgeon and the electrophysiologist, which allows electrophysiological measurements and confirmation of the ablation lines permits to make lesions in regions which cannot be reached epicardially.
Further studies are warranted to determine whether the hybrid approach is effective, especially in patients with longstanding persistent and persistent LAF.
Furthermore, the additional value of GP ablation is to be further elucidated to assess its role in minimally invasive surgery.
